You cannot buy a generic Tobi product at this time, due to a patent that prevents generic versions from being made in the United States. However, after the patent expires in October 2014, companies may begin making a generic Tobi product. Although tobramycin is sometimes referred to as the generic name for Tobi, it is simply the active ingredient in the drug.
Tobi® (tobramycin inhalation solution) is a prescription medication used to treat people with cystic fibrosis who have Pseudomonas aeruginosa bacteria in their lungs. This medicine is an inhaled antibiotic.
Tobi is made by Novartis Pharmaceuticals Corporation. It is currently protected by a patent that prevents generic versions of the medicine from being manufactured in the United States.
The patent for Tobi is set to expire in October 2014. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or delay this exclusivity period, including such things as lawsuits or other patents for new Tobi uses. Once the patent expires, there may be several companies that manufacture a generic version of this drug.
No -- tobramycin is the active ingredient in Tobi, not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.